Literature DB >> 8385462

Inhibition of rabbit lung angiotensin converting enzyme by idrapril.

A Lippi1, M Criscuoli, G Sardelli, A Subissi.   

Abstract

Idrapril, the prototype of a new class of angiotensin converting enzyme (ACE) inhibitors, competitively inhibited, with nanomolar apparent Ki, the hydrolysis of hippuryl-glycyl-glycine by rabbit lung ACE. The pre-steady-state analysis of this tight-binding inhibition showed it to be characterized by slow kinetics, but at variance with what was found for enalaprilat in the same conditions, idrapril appeared to act through a simple, single step mechanism. Kinetic Ki and k(on) and k(off) values were 470 pM, 3.0 +/- 1.5 x 10(6) M-1 sec-1 and 1.4 +/- 0.3 x 10(-3) sec-1, respectively.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385462     DOI: 10.1016/0006-2952(93)90291-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  1 in total

1.  Pharmacokinetics and biochemical efficacy of idrapril calcium, a novel ACE inhibitor, after multiple oral administration in humans.

Authors:  P J Wyld; J Grant; A Lippi; M Criscuoli; G Del Re; A Subissi
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.